The future of biotech drugs looks promising, with ongoing advancements in synthetic biology, nanotechnology, and artificial intelligence driving innovation. These technologies have the potential to create more effective and affordable treatments. Additionally, the increasing understanding of the human genome will likely lead to the development of more personalized therapies. However, addressing the ethical, regulatory, and economic challenges will be crucial for the sustainable growth of the biotech pharmaceutical industry.
